Xenpozyme 4 mg, poudre pour solution à diluer pour perfusion - Swissmedic Key 67287001 Registration Holder Sanofi-Aventis (Suisse) SA Name Xenpozyme 4 mg, poudre pour solution à diluer pour perfusion Date of registration 19.12.2023 Introduction of Sequence 19.12.2023 ATC-Classification (Codice) Revision date WHO Valid until 18.12.2028 Index Therapeuticus (BSV) Show package size Index Therapeuticus (Swissmedic) 07.99. Description Swissmedic categorie. A SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680672870014 Medication Code Biotechnologika Pharmacode Disponibility
Composition Praeparatio cryodesiccata: olipudasum alfa 4 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, saccharum, methioninum, pro vitro corresp. natrium 0.6 mg. Packungsbestandteile Label Praeparatio cryodesiccata:
Galenic Form poudre pour solution à diluer pour perfusion Excipiens Active Agent Dose Olipudasum Alfa 4 mg
Inactive agents Disodium Phosphate Heptahydrate Methionine Sodium Dihydrogenophosphate Monohydrate Saccharum
Source Data was imported : 05.01.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
